These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 3252975)

  • 1. Melarsoprol toxicity in the treatment of human African trypanosomiasis. Ten cases treated with dimercaprol.
    Scena MR
    Cent Afr J Med; 1988 Nov; 34(11):264-8. PubMed ID: 3252975
    [No Abstract]   [Full Text] [Related]  

  • 2. Mel B toxicity in human trypanosomiasis in the Gboko endemic area of Nigeria.
    Aiyedun BA; Amodu AA
    Acta Trop; 1976; 33(1):96-100. PubMed ID: 13638
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Arsenical-induced encephalopathy during the treatment of African trypanosomiasis. Apropos of a case with a favorable outcome].
    Pialoux G; Kernbaum S; Vachon F
    Bull Soc Pathol Exot Filiales; 1988; 81(3 Pt 2):555-6. PubMed ID: 3197251
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Complications observed in the treatment of trypanosomiasis in the Congo].
    Ginoux PY; Bissadidi N; Frezil JL
    Med Trop (Mars); 1984; 44(4):351-5. PubMed ID: 6521632
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Eflornithine is safer than melarsoprol for the treatment of second-stage Trypanosoma brucei gambiense human African trypanosomiasis.
    Chappuis F; Udayraj N; Stietenroth K; Meussen A; Bovier PA
    Clin Infect Dis; 2005 Sep; 41(5):748-51. PubMed ID: 16080099
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Adrenaline in the prevention and treatment of adverse effects of arsobal therapy. Apropos of 776 cases of human African trypanosomiasis caused by T. gambiense in the Health Service of Fontem (U.R. Cameroon)].
    Sina GC; Triolo N; Cramet B; Suh Bandu M
    Med Trop (Mars); 1982; 42(5):531-6. PubMed ID: 7154902
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Melarsoprol and reactive encephalopathy in Trypanosoma brucei rhodesiense.
    Arroz JO
    Trans R Soc Trop Med Hyg; 1987; 81(2):192. PubMed ID: 3617176
    [No Abstract]   [Full Text] [Related]  

  • 8. An unusual course of west African trypanosomiasis in a Caucasian man.
    Grau Junyent JM; Rozman M; Corachán M; Estruch R; Urbano-Marquez A
    Trans R Soc Trop Med Hyg; 1987; 81(6):931-2. PubMed ID: 3503413
    [No Abstract]   [Full Text] [Related]  

  • 9. Trial of prednisolone for prevention of melarsoprol-induced encephalopathy in gambiense sleeping sickness.
    Pepin J; Milord F; Guern C; Mpia B; Ethier L; Mansinsa D
    Lancet; 1989 Jun; 1(8649):1246-50. PubMed ID: 2566790
    [TBL] [Abstract][Full Text] [Related]  

  • 10. African trypanosomiasis and drug-induced encephalopathy: risk factors and pathogenesis.
    Pepin J; Milord F
    Trans R Soc Trop Med Hyg; 1991; 85(2):222-4. PubMed ID: 1887477
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The treatment of sleeping sickness (mainly due to Trypanosoma rhodesiense) with melarsoprol.
    ROBERTSON DH
    Trans R Soc Trop Med Hyg; 1963 May; 57():176-83. PubMed ID: 13974351
    [No Abstract]   [Full Text] [Related]  

  • 12. [2 epidemics of arsenical encephalopathy in the treatment of trypanosomiasis, Uganda, 1992-1993].
    Ancelle T; Barret B; Flachet L; Moren A
    Bull Soc Pathol Exot; 1994; 87(5):341-6. PubMed ID: 7496198
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The treatment of sleeping sickness (mainly due to Trypanosoma rhodesiense) with melarsoprol. I. Reactions observed during treatment.
    ROBERTSON DH
    Trans R Soc Trop Med Hyg; 1963 Mar; 57():122-33. PubMed ID: 13974350
    [No Abstract]   [Full Text] [Related]  

  • 14. Melarsoprol-associated multifocal inflammatory CNS illness in African trypanosomiasis.
    Kumar N; Orenstein R; Uslan DZ; Berbari EF; Klein CJ; Windebank AJ
    Neurology; 2006 Apr; 66(7):1120-1. PubMed ID: 16540605
    [No Abstract]   [Full Text] [Related]  

  • 15. An evaluation of prednisolone as a routine adjunct to the treatment of T. rhodesiense.
    Foulkes JR
    J Trop Med Hyg; 1975 Apr; 78(4):72-4. PubMed ID: 1152100
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human African trypanosomiasis: diagnosis, relapse and survival after severe melarsoprol-induced encephalopathy.
    Checkley AM; Pepin J; Gibson WC; Taylor MN; Jäger HR; Mabey DC
    Trans R Soc Trop Med Hyg; 2007 May; 101(5):523-6. PubMed ID: 17270227
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk factors for encephalopathy and mortality during melarsoprol treatment of Trypanosoma brucei gambiense sleeping sickness.
    Pépin J; Milord F; Khonde AN; Niyonsenga T; Loko L; Mpia B; De Wals P
    Trans R Soc Trop Med Hyg; 1995; 89(1):92-7. PubMed ID: 7747321
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The importance of 2,3-dimercaptopropinol (British anti-lewisite, BAL) in the trypanocidal activity of topical melarsoprol.
    Jennings FW; Atouguia JM; Murray M
    Acta Trop; 1996 Oct; 62(2):83-9. PubMed ID: 8988309
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Investigations of the metabolites of the trypanocidal drug melarsoprol.
    Keiser J; Ericsson O; Burri C
    Clin Pharmacol Ther; 2000 May; 67(5):478-88. PubMed ID: 10824626
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Trypanosomal meningo-encephalitis observed in France. Reflections concerning the use of arsobal].
    Siguier F; Betourne C; Lanza M; Herreman G; Piette F
    Bull Mem Soc Med Hop Paris; 1967 May; 118(8):717-22. PubMed ID: 6060517
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.